Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital.
Background: Infection with Hepatitis C virus (HCV) is a major cause of chronic liver disease, WHO estimated that about 170 million people are infected with Hepatitic C virus, Silymarin (Legalon) have been recently shown to be effective in treatment of Hepatitic C virus infection. Objectives: The eff...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
College of Medicine University of Baghdad
2017-04-01
|
| Edice: | مجلة كلية الطب |
| Témata: | |
| On-line přístup: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/150 |